Pediatrics - Global Oncology Academy

1-16 of 17

Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Project Oncology®
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS; Shannon Raber, MS, CPNP, RN
- Alexandria May, PharmD, BCPS
- Shannon Raber, MS, CPNP, RN
- Bridget Archambault, MSN, CPNP
Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Project Oncology®
Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Shelina Ramnarine, PhD; Mohamed Abdelbaki, MD
- Shelina Ramnarine, PhD
- Mohamed Abdelbaki, MD
3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Project Oncology®
3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Alexandria May, PharmD, BCPS; Daniel Landi, MD
- Alexandria May, PharmD, BCPS
- Daniel Landi, MD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALL
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley; Amanda Winters, MD, PhD
- Ryan Quigley
- Amanda Winters, MD, PhD
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALL
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Charles Turck, PharmD, BCPS, BCCCP; Lena Winestone, MD, MSHP
- Charles Turck, PharmD, BCPS, BCCCP
- Lena Winestone, MD, MSHP
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstracts
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Ryan Quigley
- Ryan Quigley
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD; Daniel J. DeAngelo, MD, PhD
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS; Nicholas Whipple, MD, MPH
- Alexandria May, PharmD, BCPS
- Nicholas Whipple, MD, MPH
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Ryan Quigley; Kathrin M. Bernt, MD
- Ryan Quigley
- Kathrin M. Bernt, MD
- Rushabh Mehta, BS
- Fatemeh Alikarami
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Alexandria May, PharmD, BCPS; Daniel Landi, MD
- Alexandria May, PharmD, BCPS
- Daniel Landi, MD
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Project Oncology®
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Alexandria May, PharmD, BCPS; Angela Waanders, MD, MPH, MS
- Alexandria May, PharmD, BCPS
- Angela Waanders, MD, MPH, MS
- Ashley S. Margol, MD, MS
Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
Clinician's Roundtable
Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Project Oncology®
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Pediatric Oncofertility: Key Considerations & Procedures
Pediatric Oncofertility: Key Considerations & Procedures
Project Oncology®
Pediatric Oncofertility: Key Considerations & Procedures
Jacob Sands, MD; Yasmin Jayasinghe, FRANZCOG, PhD
- Jacob Sands, MD
- Yasmin Jayasinghe, FRANZCOG, PhD
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Immuno-Oncology (IO) Updates
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Shira Johnson, MD; Robert Vonderheide, MD
- Shira Johnson, MD
- Robert Vonderheide, MD
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
Focus on Children's Health
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
Bruce Bloom, DDS, JD; Stephen Hunger, MD
- Bruce Bloom, DDS, JD
- Stephen Hunger, MD

Prev
1
2
Next

1/2